920
Views
0
CrossRef citations to date
0
Altmetric
Chronic Kidney Disease and Progression

Genetic association study of TERT gene variants with chronic kidney disease susceptibility in the Chinese population

, , , &
Article: 2300725 | Received 04 Aug 2023, Accepted 26 Dec 2023, Published online: 10 Jan 2024

References

  • Luan ZL, Zhang C, Ming WH, et al. Nuclear receptors in renal health and disease. EBioMedicine. 2022;76:1. doi:10.1016/j.ebiom.2022.103855.
  • Levey AS, Becker C, Inker LA. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review. JAMA. 2015;313(8):837–10. doi:10.1001/jama.2015.0602.
  • Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health. 2008;8(1):117. doi:10.1186/1471-2458-8-117.
  • Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018;392(10159):2052–2090. doi:10.1016/S0140-6736(18)31694-5.
  • Bash LD, Astor BC, Coresh J. Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis. 2010;55(1):31–41. doi:10.1053/j.ajkd.2009.09.006.
  • Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–1305. doi:10.1056/NEJMoa041031.
  • Balakumar P, Chakkarwar VA, Kumar V, et al. Experimental models for nephropathy. J Renin Angiotensin Aldosterone Syst. 2008;9(4):189–195. doi:10.1177/1470320308098343.
  • Kastarinen M, Juutilainen A, Kastarinen H, et al. Risk factors for end-stage renal disease in a community-based population: 26-year follow-up of 25,821 men and women in Eastern Finland. J Intern Med. 2010;267(6):612–620. doi:10.1111/j.1365-2796.2009.02197.x.
  • Köttgen A. Genome-wide association studies in nephrology research. Am J Kidney Dis. 2010;56(4):743–758. doi:10.1053/j.ajkd.2010.05.018.
  • Ding D, Zhou J, Wang M, et al. Implications of telomere-independent activities of telomerase reverse transcriptase in human cancer. FEBS J. 2013;280(14):3205–3211. doi:10.1111/febs.12258.
  • Blackburn EH. Telomeres and telomerase: the means to the end (nobel lecture). Angew Chem Int Ed Engl. 2010;49(41):7405–7421. doi:10.1002/anie.201002387.
  • Willeit P, Willeit J, Mayr A, et al. Telomere length and risk of incident cancer and cancer mortality. Jama. 2010;304(1):69–75. doi:10.1001/jama.2010.897.
  • Mazidi M, Rezaie P, Covic A, et al. Telomere attrition, kidney function, and prevalent chronic kidney disease in the United States. Oncotarget. 2017;8(46):80175–80181. doi:10.18632/oncotarget.20706.
  • Ameh OI, Okpechi IG, Dandara C, et al. Association between telomere length, chronic kidney disease, and renal traits: a systematic review. OMICS. 2017;21(3):143–155. doi:10.1089/omi.2016.0180.
  • Long Q, Hua Y, He L, et al. Poly(U) binding splicing factor 60 promotes renal cell carcinoma growth by transcriptionally upregulating telomerase reverse transcriptase. Int J Biol Sci. 2020;16(15):3002–3017. doi:10.7150/ijbs.45115.
  • Ma R, Liu C, Lu M, et al. The TERT locus genotypes of rs2736100-CC/CA and rs2736098-AA predict shorter survival in renal cell carcinoma. Urol Oncol. 2019;37(5):301.e1–301.e10. doi:10.1016/j.urolonc.2019.01.014.
  • Casuscelli J, Becerra MF, Manley BJ, et al. Characterization and impact of TERT promoter region mutations on clinical outcome in renal cell carcinoma. Eur Urol Focus. 2019;5(4):642–649. doi:10.1016/j.euf.2017.09.008.
  • Lin Y, Yin P, Zhu Z, et al. Epigenome-wide association study and network analysis for IgA nephropathy from CD19(+) B-cell in chinese population. Epigenetics. 2021;16(12):1283–1294. doi:10.1080/15592294.2020.1861171.
  • Han Q, Geng W, Zhang D, et al. ADIPOQ rs2241766 gene polymorphism and predisposition to diabetic kidney disease. J Diabetes Res. 2020;2020:5158497–5158498. doi:10.1155/2020/5158497.
  • Sun Q, Liu J, Cheng G, et al. The telomerase gene polymorphisms, but not telomere length, increase susceptibility to primary glomerulonephritis/end stage renal diseases in females. J Transl Med. 2020;18(1):184. doi:10.1186/s12967-020-02347-3.
  • Tomson CRV, Cheung AK, Mann JFE, et al. Management of blood pressure in patients with chronic kidney disease not receiving dialysis: synopsis of the 2021 KDIGO clinical practice guideline. Ann Intern Med. 2021;174(9):1270–1281. doi:10.7326/M21-0834.
  • de Martino M, Taus C, Lucca I, et al. Association of human telomerase reverse transcriptase gene polymorphisms, serum levels, and telomere length with renal cell carcinoma risk and pathology. Mol Carcinog. 2016;55(10):1458–1466. doi:10.1002/mc.22388.
  • Singh V, Jaiswal PK, Mittal RD. Replicative study of GWAS TP63C/T, TERTC/T, and SLC14A1C/T with susceptibility to bladder cancer in North indians. Urol Oncol. 2014;32(8):1209–1214. doi:10.1016/j.urolonc.2014.05.013.
  • Dratwa M, Wysoczańska B, Łacina P, et al. TERT-Regulation and roles in cancer formation. Front Immunol. 2020;11:589929. doi:10.3389/fimmu.2020.589929.
  • Chang WW, Su H, He L, et al. Association between transforming growth factor-beta1 T869C polymorphism and rheumatoid arthritis: a meta-analysis. Rheumatology (Oxford). 2010;49(4):652–656. doi:10.1093/rheumatology/kep417.
  • Kłoda K, Domanski L, Kwiatkowska E, et al. hTERT, BICD1 and chromosome 18 polymorphisms associated with telomere length affect kidney allograft function after transplantation. Kidney Blood Press Res. 2015;40(2):111–120. doi:10.1159/000368487.
  • Sheng X, Tong N, Tao G, et al. TERT polymorphisms modify the risk of acute lymphoblastic leukemia in chinese children. Carcinogenesis. 2013;34(1):228–235. doi:10.1093/carcin/bgs325.
  • Gnanasambandan R, Elumalai R, Soundararajan P, et al. Angiotensinogen gene polymorphisms and progression of chronic kidney disease in ADPKD patients. Clin Exp Nephrol. 2016;20(4):561–568. doi:10.1007/s10157-015-1183-2.
  • Cobo G, Hecking M, Port FK, et al. Sex and gender differences in chronic kidney disease: progression to end-stage renal disease and haemodialysis. Clin Sci (Lond). 2016;130(14):1147–1163. doi:10.1042/CS20160047.
  • Kobayashi H, Otsuka H, Yanai M, et al. Adiponectin receptor gene polymorphisms are associated with kidney function in elderly Japanese populations. J Atheroscler Thromb. 2019;26(4):328–339. doi:10.5551/jat.45609.
  • Mills KT, Xu Y, Zhang W, et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015;88(5):950–957. doi:10.1038/ki.2015.230.
  • Chung HF, Long KZ, Hsu CC, et al. Adiponectin gene (ADIPOQ) polymorphisms correlate with the progression of nephropathy in Taiwanese male patients with type 2 diabetes. Diabetes Res Clin Pract. 2014;105(2):261–270. doi:10.1016/j.diabres.2014.04.015.
  • Niu D, Gao Y, Xie L, et al. Genetic polymorphisms in TNFSF13 and FDX1 are associated with IgA nephropathy in the han Chinese population. Hum Immunol. 2015;76(11):831–835. doi:10.1016/j.humimm.2015.09.044.
  • Misiti S, Nanni S, Fontemaggi G, et al. Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells. Mol Cell Biol. 2000;20(11):3764–3771. doi:10.1128/MCB.20.11.3764-3771.2000.
  • Vidal JD, Register TC, Gupta M, et al. Estrogen replacement therapy induces telomerase RNA expression in the macaque endometrium. Fertil Steril. 2002;77(3):601–608. doi:10.1016/s0015-0282(01)03227-7.
  • Liu R, Li G, Cui XF, et al. Methodological evaluation and comparison of five urinary albumin measurements. J Clin Lab Anal. 2011;25(5):324–329. doi:10.1002/jcla.20477.
  • MacIsaac RJ, Ekinci EI, Jerums G. Progressive diabetic nephropathy. How useful is microalbuminuria: contra. Kidney Int. 2014;86(1):50–57. doi:10.1038/ki.2014.98.
  • Dahlström J, Liu T, Yuan X, et al. TERT rs2736100 genotypes are associated with differential risk of myeloproliferative neoplasms in Swedish and Chinese male patient populations. Ann Hematol. 2016;95(11):1825–1832. doi:10.1007/s00277-016-2787-7.
  • Liu ZH. Nephrology in China. Nat Rev Nephrol. 2013;9(9):523–528. doi:10.1038/nrneph.2013.146.